Skip to main content
  • 1365 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Swick, M (1978) Radiographic media in urology, the discovery of excretion urography. Surgical Clinics of North America 58: 977–994

    PubMed  Google Scholar 

  2. Grainger RG, Thomas AMK (1999) History of the development of radiological contrast agents (1895–1996). In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. Pp3–14

    Google Scholar 

  3. Cameron D (1917) Aqueous solutions of potassium & sodium iodides as opaque media in roentgenography. J American Medical Association 70: 754–755

    Google Scholar 

  4. Osborne ED, Sutherland CG, Scholl AJ Jr, Rowntree LG (1923) Roentgenology of the urinary tract during excretion of sodium iodide. American Medical Association 80: 368–373

    Google Scholar 

  5. Swick M (1929) Darstellung der Niere und Harnwege in Roentgenbild durch intravenöse Einbringung eines neuen Kontraststoffes: des Uroselectans. Klinische Wochenschrift 8: 2087–2089

    Article  Google Scholar 

  6. Von Lichtenberg A, Swick M (1929) Klinische Prüfung des Uroselectans. Klinische Wochenschrift 8: 2089–2091

    Article  Google Scholar 

  7. Wallingford VH (1953) The development of organic iodide compounds as X-ray contrast media. Journal of American Pharmacological Association (Scientific Edition) 42: 721–728

    Google Scholar 

  8. Hoppe JO, Larsen HA, Coulston FJ (1956) Observations on the toxicity of a new urographic contrast medium, sodium 3,5-diacetamido-2, 4, 6 tri-iodobenzoate (Hypaque sodium) and related compounds. Journal of Pharmacological and Experimental Therapeutics 116: 394–403

    Google Scholar 

  9. Grainger RG (1982) Intravascular contrast media — the past, the present and the future. British Journal of Radiology 55: 1–18

    PubMed  Google Scholar 

  10. Almén T (1969) Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality. Journal of Theoretical Biology 24: 216–226

    PubMed  Google Scholar 

  11. Amdam RP, Sogner K (1994) Wealth of contrasts. Oslo: Ad Notam Gyldendal

    Google Scholar 

  12. Dawson P, Grainger RG, Pitfield J (1983) The new low-osmolar contrast media: a simple guide. Clinical Radiology 34: 221–226

    Article  PubMed  Google Scholar 

  13. Dawson P, Saini S, Schild H, Niendorf HP, Schlieff R (1994) Continuing progress in contrast agents. Imaging 6: 273–284

    Google Scholar 

  14. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 348: 491–499

    Article  PubMed  Google Scholar 

  15. Almén T (1985) Development of non-ionic contrast media. Investigative Radiology 20: 2–9

    PubMed  Google Scholar 

  16. Weinmann HJ (1999) Gadolinium chelates: physico-chemical properties, formulation and toxicology. In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. pp 297–318

    Google Scholar 

  17. Lauterbur PC, Mendonça-Dias H, Rudin AM (1978) Augmentation of tissue proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions. in: Dutton PO, Leigh J, Scarpa A (eds). Frontiers of Biological Energetics. New York: Academic Press pp 752–759

    Google Scholar 

  18. Haën C (2001) Conception of the first magnetic resonance imaging contrast agents: a brief history. Topics in Magnetic Resonance Imaging 12: 221–230

    Article  PubMed  Google Scholar 

  19. Carr D, Brown I, Bydder G, Weinmann HJ, Speck U, Thomas DJ, Young IR (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet i: 484–486

    Article  Google Scholar 

  20. Weinmann HJ, Brasch RC, Press WR, Wesby GE (1984) Characteristics of gadolinium-DT-PA complex: a potential NMR contrast agent. AJR 142: 619–624

    PubMed  Google Scholar 

  21. Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. Am J Roentgenology 142: 625–630

    Google Scholar 

  22. Claussen C, Laniado M, Schörner W, et al. (1985) Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. Am J Neuroradiol 6: 669–674

    PubMed  Google Scholar 

  23. Weinmann HJ (2003) History of MRI contrast media development, accompanied by Magnevist. 15 years of Magnevist, Satellite Symposium: ECR 2003

    Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). Contrast Agents. In: Thomas, A.M., Banerjee, A.K., Busch, U. (eds) Classic Papers in Modern Diagnostic Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26988-6_6

Download citation

  • DOI: https://doi.org/10.1007/3-540-26988-6_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21927-9

  • Online ISBN: 978-3-540-26988-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics